171 related articles for article (PubMed ID: 26842207)
1. Retrospective analysis of clinicopathological factors and outcome in breast cancer in young women in a tertiary care hospital in India.
Deshmukh SP; Mane AD; Zade BP; Sane SP
Indian J Cancer; 2014; 51(4):594-8. PubMed ID: 26842207
[TBL] [Abstract][Full Text] [Related]
2. Young breast cancer: A single center experience.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
Indian J Cancer; 2014; 51(4):604-8. PubMed ID: 26842210
[TBL] [Abstract][Full Text] [Related]
3. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy?
Coelho RC; Da Silva FML; Do Carmo IML; Bonaccorsi BV; Hahn SM; Faroni LD
Breast; 2017 Feb; 31():192-196. PubMed ID: 27889595
[TBL] [Abstract][Full Text] [Related]
5. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Coates AS; Winer EP; Goldhirsch A; Gelber RD; Gnant M; Piccart-Gebhart M; Thürlimann B; Senn HJ;
Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896
[TBL] [Abstract][Full Text] [Related]
6. [Treatment patterns and affecting factors in breast cancer patients over 65-years of age].
Mao Y; Chen X; Gao W; Liu J; Shen K
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):366-71. PubMed ID: 25030593
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
8. [Primary systemic therapy in breast cancer patients (2007-2010)].
Zapf I; Tizedes G; Pavlovics G; Kovács G; Kálmán E; Szalai G; Kövér E; Farkas R; Horváth OP
Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
[TBL] [Abstract][Full Text] [Related]
10. Male breast cancer: A 10 year retrospective case series in a tertiary care hospital.
Yetkin G; Celayir MF; Tanik C; Citgez B; Uludag M; Mihmanli M
J Pak Med Assoc; 2019 Aug; 69(8):1209-1212. PubMed ID: 31431782
[TBL] [Abstract][Full Text] [Related]
11. High expression of post-treatment Ki-67 status is a risk factor for locoregional recurrence following breast-conserving surgery after neoadjuvant chemotherapy.
Yamazaki N; Wada N; Yamauchi C; Yoneyama K
Eur J Surg Oncol; 2015 May; 41(5):617-24. PubMed ID: 25771264
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
Cefaro GA; Genovesi D; Trignani M; DI Nicola M
Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and prognosis study of breast carcinoma with micropapillary component].
Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Fu L
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):228-32. PubMed ID: 17706112
[TBL] [Abstract][Full Text] [Related]
14. Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Blum JL; Flynn PJ; Yothers G; Asmar L; Geyer CE; Jacobs SA; Robert NJ; Hopkins JO; O'Shaughnessy JA; Dang CT; Gómez HL; Fehrenbacher L; Vukelja SJ; Lyss AP; Paul D; Brufsky AM; Jeong JH; Colangelo LH; Swain SM; Mamounas EP; Jones SE; Wolmark N
J Clin Oncol; 2017 Aug; 35(23):2647-2655. PubMed ID: 28398846
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological profile of breast cancer: An institutional experience.
Gogia A; Deo SV; Shukla NK; Mathur S; Sharma DN; Tiwari A
Indian J Cancer; 2018; 55(3):210-213. PubMed ID: 30693880
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
[TBL] [Abstract][Full Text] [Related]
18. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
19. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.
Caudle AS; Gonzalez-Angulo AM; Hunt KK; Liu P; Pusztai L; Symmans WF; Kuerer HM; Mittendorf EA; Hortobagyi GN; Meric-Bernstam F
J Clin Oncol; 2010 Apr; 28(11):1821-8. PubMed ID: 20231683
[TBL] [Abstract][Full Text] [Related]
20. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit?
Yadav BS; Sharma SC; George P; Bansal A
J Cancer Res Ther; 2014; 10(2):279-83. PubMed ID: 25022378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
